Your SlideShare is downloading. ×
Pharmaceutical Industry In China Q3 2013 : Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Pharmaceutical Industry In China Q3 2013 : Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

184
views

Published on

Biz:Pharmaceutical Industry In China Q3 2013 : Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges …

Biz:Pharmaceutical Industry In China Q3 2013 : Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges


To Read The Complete Report Visit:
http://www.marketresearchreports.biz/analysis-details/pharmaceutical-industry-in-china-q3-2013-cutting-edge-analysis-of-multinational-and-chinese-pharma-companies-industry-trends-environment-regulation-market-drivers-restraints-opportunities-and-challenges


Blog: http://marketpress.blog.com/

Published in: Business, News & Politics

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
184
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pharmaceutical Industry In China Q3 2013 - Cutting-Edge Analysis Of Multinational And Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges This report tackles not only global pharmaceutical company interest in China but also home grown companies and their battle for position. The business environment in which they compete is analysed as are key drivers, constraints, challenges and opportunities. The Chinese Pharmaceutical market is currently the third greatest pharma market globally, after the US and Japan, and in 2011 was worth $x. It is forecast to increase dramatically to $x by 2015 and increase its dominance as a leading player in Asia. As the current third market leader it is predicted that the Chinese pharma market will be the main competitor of the US by 2020. Click Here To Download Sample Report:http://www.marketresearchreports.biz/analysisdetails/pharmaceutical-industry-in-china-q3-2013-cutting-edgeanalysis-of-multinational-and-chinese-pharma-companiesindustry-trends-environment-regulation-market-driversrestraints-opportunities-and-challenges This report describes the current therapeutics that are propelling the biopharmaceutical market in China. It examines the current economic climate and how China compares to other emerging markets and also evolved markets such as the US and Europe. Current developments relating to patent expirations,
  • 2. government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, diabetes and vaccines are elucidated and analysed. This study reveals market figures of the overall Chinese pharmaceutical market and sub-markets. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. The study also provides a comprehensive financial and product review of key players in the biopharmaceutical industry in China. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified. In summary, the Chinese biopharmaceutical market has huge opportunities for growth. This industry will significantly affect the international healthcare market and has enormous potential for investment. Pharmaceutical Industry China Q3 2013 – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 196 tables & figures within 145 pages. The Chinese biopharmaceutical market is presented as follows:  By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)
  • 3.  By Therapeutic Area (e.g., Antiinfective, Cancer, Diabetes, Dementia, Depression) A wealth of financial information is provided including:       Company financials, sales & revenue figures – historical to Q2•2013 China GDP, economic growth, export (bulk drug, formulations) figures Indian health expenditure as a function of GDP Growth change figures of emerging and developing countries (India, Russia, China, Brazil) Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada) Projected figures of strategic emerging industry GDP percentage contribution SWOT, Economic and Business Environment specifics include:         Key strengths, weaknesses and threats influencing leading player position within the market Top Five Contract Pharmaceutical Export Markets of China Major players within China’s leading therapeutic markets (e.g., cancer, allergy, liver disease) Multinational penetration into the Chinese Pharma Market Comprehensive product portfolios, R&D activity and pipeline therapeutics M&A activity and future strategies of top Chinese pharmacos Economic indicators, trade policy, merchandise and commercial trade statistics Gross Domestic Product of China, historic and projection analysis
  • 4.     Chinese economic outlook in comparison to advanced economies Three Tier ‘Pharmerging’ Markets with Potential for Significant Growth Prescription drug sales distribution channels in China Major biogeneric products in China To Download Sample Report Visit:http://www.marketresearchreports.biz/sample/sample/177632 This report highlights a number of significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy.                 Amoytop Biotech Active Pharmaceutical Products Beijing Continent Pharmaceuticals FusoGen Pharmaceuticals Shanghai Huaguan Biochip SiBiono GeneTech Abbott AstraZeneca Boehringer Ingelheim Eli Lilly GlaxoSmithKline Johnson & Johnson Medical Merck Novartis Pfizer Roche
  • 5. Forecast projections and future growth rates are provided to give you a forthcoming perspective of this growing industry. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed. What you will gain:        An in-depth understanding of the Chinese biopharmaceutical market and it’s environment Current market facts, figures and product lines of key players in the industry An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market Knowledge of how the Chinese pharma market will integrate into the global healthcare market Information on key regulatory and government policies Data on levels of private and publically funded biopharma studies in China Strategies on how to adapt and restructure current business models to this industry This report tackles key concerns biopharmaceutical market such as:     to Lack of regulatory policy and legislation Reimbursement schemes and payers concerns Funding and government sponsorship issues International scepticism of Chinese safety therapeutic profiles the and Chinese efficacy
  • 6. This report will tell you if the companies mentioned are:     Strong, competitive players Pooling their resources for specific growth and therapeutic areas Investing strategically in R&D Have a history of strategic M&A activity About Us MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
  • 7. Contact M/s Sheela 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-997-4948 Website: http://www.marketresearchreports.biz/ Blog: http://marketpresss.blogspot.com